NO20001779L - Krystallinsk, polymorf antisoppforbindelse - Google Patents

Krystallinsk, polymorf antisoppforbindelse

Info

Publication number
NO20001779L
NO20001779L NO20001779A NO20001779A NO20001779L NO 20001779 L NO20001779 L NO 20001779L NO 20001779 A NO20001779 A NO 20001779A NO 20001779 A NO20001779 A NO 20001779A NO 20001779 L NO20001779 L NO 20001779L
Authority
NO
Norway
Prior art keywords
polymorphic
crystalline
antifungal compound
antifungal
compound
Prior art date
Application number
NO20001779A
Other languages
English (en)
Other versions
NO318827B1 (no
NO20001779D0 (no
Inventor
David R Andrews
William Leong
Anantha R Sudhakar
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20001779D0 publication Critical patent/NO20001779D0/no
Publication of NO20001779L publication Critical patent/NO20001779L/no
Publication of NO318827B1 publication Critical patent/NO318827B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20001779A 1997-10-07 2000-04-06 Krystallinsk, polymorf antisoppforbindelse, farmasoytiske preparater inneholdende en slik forbindelse og anvendelse av en slik forbindelse NO318827B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07
PCT/US1998/020476 WO1999018097A1 (en) 1997-10-07 1998-10-05 Crystalline antifungal polymorph

Publications (3)

Publication Number Publication Date
NO20001779D0 NO20001779D0 (no) 2000-04-06
NO20001779L true NO20001779L (no) 2000-06-06
NO318827B1 NO318827B1 (no) 2005-05-09

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001779A NO318827B1 (no) 1997-10-07 2000-04-06 Krystallinsk, polymorf antisoppforbindelse, farmasoytiske preparater inneholdende en slik forbindelse og anvendelse av en slik forbindelse

Country Status (31)

Country Link
EP (1) EP1021439B1 (no)
JP (4) JP2001519346A (no)
KR (1) KR100626109B1 (no)
CN (1) CN1125067C (no)
AR (1) AR015947A1 (no)
AT (1) ATE263163T1 (no)
AU (1) AU759982B2 (no)
BR (1) BR9812866A (no)
CA (1) CA2305803C (no)
CO (1) CO4970829A1 (no)
CZ (1) CZ299835B6 (no)
DE (1) DE69822859T2 (no)
DK (1) DK1021439T3 (no)
ES (1) ES2217594T3 (no)
HK (1) HK1029588A1 (no)
HU (1) HU225233B1 (no)
ID (1) ID29290A (no)
IL (1) IL135331A (no)
IN (1) IN1998CH02232A (no)
MX (1) MX225999B (no)
MY (1) MY130126A (no)
NO (1) NO318827B1 (no)
NZ (1) NZ503662A (no)
PE (1) PE120499A1 (no)
PH (1) PH11998002606B1 (no)
PL (1) PL189317B1 (no)
PT (1) PT1021439E (no)
SK (1) SK285190B6 (no)
TW (1) TW589310B (no)
WO (1) WO1999018097A1 (no)
ZA (1) ZA989063B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2451805A1 (en) 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole
RU2588570C2 (ru) 2010-05-19 2016-07-10 Сандоз Аг Способ получения хиральных гидразидов
RU2580318C2 (ru) 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
US9040539B2 (en) 2010-05-19 2015-05-26 Sandoz Ag Process for the preparation of chiral triazolones
BR112012029228A2 (pt) 2010-05-19 2021-08-03 Sandoz Ag processo para a preparação de um sal de cloreto de hidrogênio, sal de cloreto de hidrogênio, sal de cloreto de hidrogênio cristalino, uso de um sal e uso do processo
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
US9102664B2 (en) 2011-09-19 2015-08-11 Msn Laboratories Private Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
EP3024828B1 (en) * 2013-07-25 2017-05-17 Sandoz AG Improved process for the preparation of crystalline form iv of posaconazole
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
US10385078B2 (en) 2014-10-21 2019-08-20 Ariad Pharmaceuticals, Inc. Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine
WO2017025292A1 (en) 2015-08-08 2017-02-16 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant formulation containing posaconazole
US10836745B2 (en) 2015-12-24 2020-11-17 Takeda Pharmaceutical Company Limited Cocrystal, production method thereof, and medicament containing cocrystal
EP3925601A1 (en) 2016-02-26 2021-12-22 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
DK0736030T3 (da) * 1993-12-21 2001-10-29 Schering Corp Fungicide tetrahydrofuraner
PL181947B1 (en) * 1994-01-24 2001-10-31 Janssen Pharmaceutica Nv Water-soluble azole-type antimycotic agents
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
WO1996038443A1 (en) * 1995-06-02 1996-12-05 Schering Corporation Tetrahydrofuran antifungals

Also Published As

Publication number Publication date
ES2217594T3 (es) 2004-11-01
HU225233B1 (en) 2006-08-28
PT1021439E (pt) 2004-07-30
CZ20001264A3 (cs) 2000-08-16
CN1281449A (zh) 2001-01-24
DK1021439T3 (da) 2004-05-10
AU759982B2 (en) 2003-05-01
PL189317B1 (pl) 2005-07-29
JP2012153729A (ja) 2012-08-16
PH11998002606B1 (en) 2006-08-10
JP2001519346A (ja) 2001-10-23
MX225999B (es) 2005-02-02
EP1021439B1 (en) 2004-03-31
CO4970829A1 (es) 2000-11-07
HK1029588A1 (en) 2001-04-06
KR20010030959A (ko) 2001-04-16
CN1125067C (zh) 2003-10-22
ID29290A (id) 2001-08-16
PE120499A1 (es) 1999-12-04
HUP0004899A2 (hu) 2002-02-28
NO318827B1 (no) 2005-05-09
MY130126A (en) 2007-06-29
CA2305803A1 (en) 1999-04-15
AU9780398A (en) 1999-04-27
IL135331A (en) 2005-08-31
AR015947A1 (es) 2001-05-30
CA2305803C (en) 2009-12-22
NZ503662A (en) 2002-10-25
EP1021439A1 (en) 2000-07-26
BR9812866A (pt) 2000-08-08
IN1998CH02232A (no) 2005-03-04
SK5122000A3 (en) 2000-09-12
WO1999018097A1 (en) 1999-04-15
PL339659A1 (en) 2001-01-02
ZA989063B (en) 1999-04-06
SK285190B6 (sk) 2006-08-03
JP2012153730A (ja) 2012-08-16
HUP0004899A3 (en) 2002-03-28
ATE263163T1 (de) 2004-04-15
TW589310B (en) 2004-06-01
DE69822859D1 (de) 2004-05-06
IL135331A0 (en) 2001-05-20
MXPA00003404A (es) 2000-11-01
DE69822859T2 (de) 2005-01-27
JP2008106075A (ja) 2008-05-08
NO20001779D0 (no) 2000-04-06
CZ299835B6 (cs) 2008-12-10
KR100626109B1 (ko) 2006-09-20

Similar Documents

Publication Publication Date Title
NO20001779L (no) Krystallinsk, polymorf antisoppforbindelse
NO982599D0 (no) Antifungale sammensetninger med forbedret biotilgjenelighet
LTC1124961I2 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
ID20744A (id) Senyawa 2-metoksibenzopenona untuk fungisida
NO20004299D0 (no) Organiske forbindelser
NO20011745L (no) Forbindelser
FI4209U1 (fi) Uusia yhdisteitä
DE59810818D1 (de) Fügeverbindung
NL1009835A1 (nl) Vloeibaar-kristallijne verbindingen.
ID24571A (id) Senyawa tienopirimidin
NO20020030D0 (no) Krystallinske 1-metylcarbapenemforbindelser
NO20005006D0 (no) Kalsilytiske forbindelser
ATE272622T1 (de) 2-(2-chlorphenyl)-3,4-dihydro-2h-pyrrol-derivat
NO20006662L (no) Fluorfenylresin-forbindelser
NL1013844A1 (nl) Sterisch gehinderde amineverbindingen.
ID20635A (id) Senyawa metalosen
SE9700751D0 (sv) Polymorphic compounds
SE9602477D0 (sv) Polymorphic compounds
SE9800458D0 (sv) Novel compounds
SE9804493D0 (sv) Novel compounds
SE9801397D0 (sv) Novel compounds
SE9804494D0 (sv) Novel compounds
SE9801989D0 (sv) Novel compounds

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MK1K Patent expired